main reasons for the development of antibiotic-resistant strains of super-bacteria is that patients only continue taking medication until they feel better, not for the duration that a physician has mandated.
Compliance has frequently been regarded as a marketing issue for healthcare authorities, who wish to ensure that patients receive optimal care; for pharmaceutical fi rms, who are concerned that consumers who are prescribed their products consume them as intended; and for physicians who see it as an important mechanism in the healing cycle, and because they have the best interests of the patient in mind, view it as the way in which patients will achieve the best results. Compliance is a marketing issue from two perspectives: From the provider-physician ' s perspective, the essential concern is in determining what the characteristics are of those physicians who are more successful in obtaining compliance, and what the strategies are that they use to achieve this.
From a patient or customer perspective, there is an interest in the characteristics of those individuals who exhibit either low or high tendencies to comply. In simple terms, it is a market segmentation and targeting issue. If we know the characteristics of patients with a lower propensity to comply, it is easier to focus marketing effort on them in an attempt to motivate them to conform. These characteristics may be behavioural, and could be related to aspects of personality and attitude. Alternatively, such characteristics may simply be demographic. It is possible that compliance is a function of fundamental demographic characteristics such as age, level of education, gender and so forth.
By focusing on such characteristics, it is considered that this research will add to our understanding of the area, and provide useful insights for managerial practitioners, such as pharmaceutical suppliers, as well as physicians that are often grappling with these fundamental issues. In addition, it is also believed that the fi ndings may prove to be of further interest for academicians who are actively engaged in research within medical markets. This paper presents the results from a large demographic study of compliance, based on data obtained from South African townships. It is structured as follows: First, some of the literature with specifi c reference to compliance as a marketing and consumer behaviour issue is reviewed. Secondly, the subject of compliance issues is outlined, as well as the research objectives and methodology. Thirdly, the results of the study are discussed and the paper concludes by identifying the study ' s limitations and its practical implications, before identifying avenues for future research.
BACKGROUND

Compliance -The marketing perspective
In noting that the actual performance of drugs in real-world clinical settings seldom approach those outcomes attained in controlled trials, Lindstr ö m and Bingefors 1 note a number of factors that can infl uence compliance. These include drug type and formulation, the patient, the status of the disease, the physician ' s characteristics, the type of healthcare system and the role of community care and family. As long ago as 1976, Komaroff 2 observed that research in the previous 20 years had provided a sophisticated understanding of what goes on when medication is prescribed. He noted, however, investigations of patient drug-taking behaviour indicated that an unsuccessful outcome may not refl ect on the potency of the medication, or the biology of the patient; rather, the drug may not have been taken as prescribed.
Various methodologies had been used to study patient compliance, ranging from simple pill counts to the use of medication dispensers using radioactive material and photographic fi lm to record the regularity with which medication packets were removed. Many factors can infl uence patient drug-taking behaviour, factors which are refl ections of the patient, the practitioner and the patient -practitioner relationship. More recent research has demonstrated the very real concerns that physicians have about their patients ' unwillingness to comply. For example, Daugherty et al . 3 surveyed 31 physicians who perceived that between one-third and two-thirds of patients do not comply with instructions, and that nearly one-third of those who comply do not show optimal treatment response. The physicians expressed concerns about the validity and cost of complementary approaches that might increase medical compliance and enhance treatment response.
One of the earliest and still most important studies of physician compliance was the work of Friedman and Churchill, 4 who considered the implications of personal infl uence research on the effectiveness of physician -patient encounters. A signifi cant contribution of the study was the development of a short, psychometrically sound instrument to measure physician compliance. More recently, Hausman 5 has argued that physician -patient service encounters may be different from other service marketing experiences in that they involve (1) oneon-one interactions, (2) frequent encounters with the same physician, (3) intimate exchanges, (4) substantial variability across encounters and (5) require patient cooperation to achieve successful health outcomes.
Just as the early work previously discussed, she argues that this type of encounter increases patient reliance on interpersonal elements to drive satisfaction. Indeed, she contends, it is these interpersonal elements of the physicianpatient interface that will encourage compliance with medical advice. The results of her study sustain the contention that interactions among these variables contribute to patient satisfaction and compliance. She also found support for the role of interpersonal interactions in loyalty and recommendation, although these relationships were found to vary depending on sample characteristics.
While physician compliance has been the subject of many studies in the medical, psychological and social marketing literatures, less attention, however, seems to have been paid to the demographics of compliance. While the focus has deservedly been on issues such as patient -physician relationships, physician behaviour and communication and the patient psychology of compliance, there is less attention given to simple questions such as, do females comply more than males (or vice versa), do better educated individuals comply more than less educated, do the wealthy comply more than the poor and does age make a difference? This paper attempts to bridge a gap in the literature, by looking to provide further insights in such areas.
The research approach
The objectives of the study were to initially describe compliance demographics in large South African townships, and secondly, to be able to predict the likelihood of compliance in a large population based on simple demographic variables. The study was conducted as part of a larger scale examination on various aspects of consumption for inhabitants of all South Africa ' s major townships, including KwaMashu, Tembisa, Soshanguve, Mamelodi, Khayelitsha, Manguang, Soweto and Vaalbank. In total, 3,500 personal interviews were conducted on adult respondents, spread more or less equally over the eight townships. South Africa ' s large townships represent an intriguing mix of emerging and developed worlds. They are populated largely by black Africans who have begun to emerge from the ravages of the apartheid system in the past ten years or so. Unlike their counterparts in informal squatter settlements, many township dwellers are employed, reasonably well educated and live above a nominal poverty line. Compared to the majority of their white compatriots, however, township dwellers are still at an economic disadvantage, in terms of income, education and general standard of living, although this gap has closed markedly in recent years. The demographic variables of concern for this investigation included gender, age, level of education, size of household, marital status and monthly household income.
For this investigation, a simplifi ed version of the Physician Compliance questionnaire 4 was used, consisting of fi ve items scored on a four-point scale (always, often, seldom, never), and a sixth item assessing overall willingness to comply ( ' Overall, do you do what your doctor instructs or asks you to do? ' ), also scored on a four-point scale (always, often, seldom, never). The 3,500 questionnaires were subjected to rigorous quality control and any incomplete questionnaires were excluded from the analysis. As a result, 2,921 fully completed questionnaires were used at the data analysis stage. This represents a very large sample size and exceeds most other demographic studies of healthcare behaviour.
DATA ANALYSIS AND RESULTS
Demographics of the study group are shown in Table 1 .
Physician compliance
The mean responses and standard deviations, to the fi ve items from the Friedman and Churchill 4 physician compliance scale are shown in Table 2 . The Cronbach Alpha (the reliability coeffi cient) for the scale was 0.56 and while this is below the generally accepted cut-off of 0.7, it is in congruence with the performance of the scale in the original research, which found an alpha of 0.55. In order to determine the dimensionality of the scale, we subjected the data to a principal components factor analysis, with varimax rotation, using the eigenvalues >1 criterion. The results of this procedure are shown in Table 3 . Items 2, 3 and 4 load strongly on factor 1; because these items all have to do with following the physician ' s orders, this factor was named as ' Conforming ' . Items 1 and 5 load strongly on factor 2, and have to do with mistrusting the physician, as a result, this factor was labelled ' Doubt ' . As a consequence of the analysis, it can be seen that physician compliance appears not to be a unidimensional construct, or at least not for the respondents in this study.
In order to at least establish a basic indication of the convergent validity of the construct, as well as to determine whether one could work with a simpler overall indication of physician compliance, multivariate regression analysis was undertaken, using the two factors as predictors of the overall measure of physician compliance (see Item 6 in Table  2 -Overall, do you do what your doctor instructs or asks you to do?). Not surprisingly, the two factors are strongly correlated with overall compliance. With an R 2 of 0.332, the impact of each of the factors is signifi cant at p < 0.001. This provides evidence of the convergent validity of the physician compliance scale. It also provides support for using the overall rating of compliance as a measure of a patient ' s willingness to comply with a physician ' s instructions.
Gender
Females demonstrated slightly higher compliance to a physician ' s instructions than males. While the R 2 was very small (0.002), the F ratio of 6.12 was signifi cant at p < 0.05.
Age demographics
There was a small but signifi cant ( R 2 of 0.01; F ratio: 8.48, p < 0.001) difference between the age groups, which showed that the older a subject, the more likely they were to comply with their physicians ' instructions.
Education
There was a small but signifi cant ( R 2 of 0.012; F ratio: 18.35, p < 0.001) difference between the groups which showed that more educated respondents were less likely to comply with a physician ' s instructions.
Marital status
Although the outcomes of the ANOVAs were more complex than in previous examples, there was still a small but signifi cant difference between the groups ( R 2 = 0.003; F ratio: 2.85, p < 0.05) which showed that widowed respondents were more likely to comply than the other groups.
Income levels
The results of this analysis can be represented by an inverted U whereby the highest and lowest income groups appear more likely to comply than middle income groups ( R 2 = 0.01; F ratio: 8.94, p < 0.001).
Household size
With a low R 2 of 0.01, the ANOVA F ratio of 5.28 was signifi cant at p < 0.001 and showed that only the large households (with seven or more inhabitants) were signifi cantly different from the rest, and in this case were more likely to comply with physician instructions.
DISCUSSION, IMPLICATIONS AND CONCLUSION
Through focusing on demographic characteristics, it is believed that the research has been able to present specifi c fi ndings that may prove interesting to the medical and healthcare sector at large. The notion of patient compliance is a signifi cant topic of debate, as by nature it has implications to a broad community of stake holders including pharmaceutical manufacturers, doctors and physicians that prescribe drugs, patients who may, or may not decide to comply, as well as national governments that operate under budgetary constraints.
Based on the fi ndings presented, six key observations can be gleaned that are worthy of being highlighted at this stage, as they may present hypotheses or avenues that prove useful for further researchers to consider when grappling with demographic issues in medical markets: (1) females tend to demonstrate greater compliance than males, (2) younger patients are less likely to comply than the relatively older, (3) the more educated are less likely to comply than the less educated, (4) marital status does signifi cantly infl uence compliance, but widowers are more likely to comply, (5) high-and low-income groups are more likely to comply, than middleincome groups and (6) large households (with seven or more) have a greater tendency to comply than other groupings.
In response, it would appear that in order to increase compliance, pharmaceutical fi rms, the South African government and physicians may need to collectively target and work specifi cally with those members of society that have a less tendency to comply. Initially it would appear that the following four categories would represent ideal segments that could be targeted in a bid to increase compliance: Members of the male population, young patients, the relatively more educated, as well as the middleincome groups. And in order to successfully implement such action (which also relates to one of the study ' s limitations), there is, however, a need for qualitative research. Although statistically, there is evidence to suggest of variations associated with demographics, further research is needed here to explain ' how ' and ' why ' such signifi cant differences occur. By attempting to tackle such issues, perhaps via focus group discussions or further personal interviews, it may be possible to draw further insights relating to different customer attitudes and values among the various sub-group demographics. The results may help to provide clues as to some of the underlying issues that drive such resistance to compliance and help pharmaceutical organisations and physicians provide more effective solutions when trying to promote and encourage patients to comply.
The researchers acknowledge that this investigation was not intended to provide fi ndings of a general nature. Practitioners are encouraged to consider the results, yet keep an open mind. As outlined, the results are very specifi c to certain subsegments of the South African population, and should not be applied out of context. Instead, further research of a similar nature that takes into account demographic attributes in other countries is urged. It would prove interesting to compare less developed nations, with developing and highly developed economies to see if signifi cant differences emerge across countries. Such fi ndings would provide interesting insights for pharmaceutical companies, physicians and national governments as they continue to grapple with issues associated with patient compliance. Can lessons learnt in one country be transferred to others? Such issues are also likely to provide stimulating debate for academics too who share an interest in medical markets.
